{"title":"Emerging Functions of the Repeat Genome in Nuclear Structure: A View from the Human Karyotype.","authors":"Lisa L Hall, Kelly P Smith, Jeanne B Lawrence","doi":"10.1146/annurev-genom-111522-014017","DOIUrl":"https://doi.org/10.1146/annurev-genom-111522-014017","url":null,"abstract":"<p><p>Collectively, various tandem and interspersed repetitive sequences make up approximately half the human genome, yet we have only begun to understand the potential functions of \"junk\" DNA. Here, we provide a brief overview of various types of repeats, but a full treatment of the repeat genome (repeatome) is beyond the scope of any review. Hence, we focus primarily on less established functions of a few major repeat classes, including pericentromeric satellites and abundant degenerate interspersed repeats, short interspersed nuclear elements (Alu), and long interspersed nuclear elements (L1). A theme developed throughout is how sequence organization in the human karyotype provides insights into potential functions within nuclear structure. For example, millions of small tandem major satellite repeats can form bodies that sequester nuclear factors, or the segmental organization of interspersed repeats may underpin the nuclear compartmentalization of heterochromatin and euchromatin. Decoding the vast repeatome is an exciting frontier being enabled by recent technological advancements. However, identifying the extent of meaningful information in repeats will likely require concepts that go well beyond impacts for individual genes, to new ways to identify and interpret broad patterns of genome-wide organization and nucleus-wide regulation.</p>","PeriodicalId":8231,"journal":{"name":"Annual review of genomics and human genetics","volume":" ","pages":""},"PeriodicalIF":7.7,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144179672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pediatric Cancer Genetics and Genomics.","authors":"Elaine R Mardis","doi":"10.1146/annurev-genom-120823-010156","DOIUrl":"https://doi.org/10.1146/annurev-genom-120823-010156","url":null,"abstract":"<p><p>Molecular profiling of DNA and RNA from pediatric cancers by next-generation sequencing has been demonstrated to improve diagnosis and prognosis and to identify somatic alterations indicating vulnerability to targeted therapies. Hence, much like in the treatment of adult cancers, molecular profiling is now routinely utilized in clinical workflows for pediatric cancers as a companion to conventional pathology diagnosis. Many variants of unknown significance identified through DNA profiling are being characterized by saturation genome editing, enabled by CRISPR editing technology and clever functional assays. Newer technologies and analytics are revealing additional structural complexity around cancer drivers and gene fusions in pediatric cancer DNA. Similarly, computational methods such as rare variant association studies and polygenic risk scoring are being used to identify novel cancer susceptibility. Together, these advances are expanding our understanding of pediatric cancer's complexity and fueling the development of emerging methods such as liquid biopsy-based monitoring.</p>","PeriodicalId":8231,"journal":{"name":"Annual review of genomics and human genetics","volume":" ","pages":""},"PeriodicalIF":7.7,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144172111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"From Tiny Exons to Big Insights: The Expanding Field of Microexons.","authors":"Tahnee Mackensen, Manuel Irimia","doi":"10.1146/annurev-genom-121323-103648","DOIUrl":"https://doi.org/10.1146/annurev-genom-121323-103648","url":null,"abstract":"<p><p>Over the last decade, a set of very short (3-51 nt) and highly conserved microexons have been found to crucially influence a set of diverse protein functions and interactions. Advancements in RNA sequencing and analysis pipelines have revealed an enrichment for the alternative splicing of microexons in a subset of tissues and cell types, especially across the central nervous system. Microexons are thought to fine-tune important developmental processes such as synaptogenesis by preserving the protein's reading frame upon inclusion. Dysregulation of microexon splicing has been linked to several neurological conditions, including autism spectrum disorder and schizophrenia, as well as metabolic disorders like diabetes and various cancer types. This review discusses the expanding body of literature on the molecular and organismal consequences of microexon inclusion, emphasizing their evolutionary conservation, tissue specificity, and functional diversity. It also explores the potential for therapeutic interventions, including pharmacological modulation, on microexon splicing and splicing regulators like SRRM3 and SRRM4, offering perspectives on targeting diseases related to microexon misregulation. More research is needed to better understand similarities and differences between microexon functions across tissues, pathologies, and species.</p>","PeriodicalId":8231,"journal":{"name":"Annual review of genomics and human genetics","volume":" ","pages":""},"PeriodicalIF":7.7,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144109574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pan Cheng, Karan Singh, Roger H Reeves, Teresa Davoli
{"title":"The Hallmarks of Aneuploidy in Cancer and Congenital Syndromes.","authors":"Pan Cheng, Karan Singh, Roger H Reeves, Teresa Davoli","doi":"10.1146/annurev-genom-111723-103557","DOIUrl":"https://doi.org/10.1146/annurev-genom-111723-103557","url":null,"abstract":"<p><p>Aneuploidy, characterized by the gain or loss of chromosomes, plays a critical role in both cancer and congenital aneuploidy syndromes. For any aneuploidy, we can distinguish between its general effects and its chromosome-specific effects. General effects refer to the common cellular stresses induced by aneuploidy, such as impaired proliferation, proteotoxic stress, and altered metabolism, which occur regardless of the specific chromosome involved and profoundly impact cellular and organismal functions. These generalized stresses often hinder cell fitness but can also, under certain conditions, contribute to cancer progression. In contrast, chromosome-specific effects arise from the altered dosage of particular genes on the gained or lost chromosome. These effects vary depending on the chromosome involved and can provide specific fitness effects in cancer cells or distinct developmental phenotypes in congenital aneuploidies like Down syndrome. Understanding the interplay between these two levels of effects is crucial for deciphering the outcomes of aneuploidy. This review synthesizes current knowledge and discusses future directions for unraveling the hallmarks of aneuploidy.</p>","PeriodicalId":8231,"journal":{"name":"Annual review of genomics and human genetics","volume":" ","pages":""},"PeriodicalIF":7.7,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143954597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Functional Neurogenomics to Dissect Disease Mechanisms Across Models.","authors":"Xinhe Zheng, Jiwen Li, Xin Jin","doi":"10.1146/annurev-genom-120823-125811","DOIUrl":"https://doi.org/10.1146/annurev-genom-120823-125811","url":null,"abstract":"<p><p>Tremendous progress has been made in identifying genetic variants associated with neurodevelopmental disorders (NDDs), particularly autism spectrum disorder (ASD). However, the extensive (and growing) lists of associated genetic variants have led to a bottleneck in understanding the function of these genetic changes. To overcome this, functional genomics approaches-including high-throughput and high-content screens, in vivo Perturb-seq, and multiomics profiling-are being deployed across cellular and animal models at scale. Here, we first discuss recent findings on NDDs gleaned from human genetics studies. We then review recent technological advances and findings from functional neurogenomics in the context of ASD and other NDDs. Finally, we discuss how these methods might be applied in the future to refine efforts to identify convergent mechanisms impacted by multiple disease-associated genetic variants, as well as how they can advance the development of new therapeutic strategies.</p>","PeriodicalId":8231,"journal":{"name":"Annual review of genomics and human genetics","volume":" ","pages":""},"PeriodicalIF":7.7,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143966137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Achille V C Manirakiza, Leon Mutesa, Christopher G Mathew, Olufunmilayo I Olopade
{"title":"Breast Cancer: Genetic Risk Assessment, Diagnostics, and Therapeutics in African Populations.","authors":"Achille V C Manirakiza, Leon Mutesa, Christopher G Mathew, Olufunmilayo I Olopade","doi":"10.1146/annurev-genom-111522-013953","DOIUrl":"https://doi.org/10.1146/annurev-genom-111522-013953","url":null,"abstract":"<p><p>Breast cancer is a major public health burden that disproportionately affects women of African descent. Substantial progress has been made in understanding the genetic and biological drivers of breast cancer worldwide. However, this knowledge is unevenly distributed among all women with breast cancer, particularly those of African descent. The highlights of nearly three decades of research among women of African descent point mainly to a young age at diagnosis, aggressive disease, and distinct biomarkers, as well as a clear geographical distribution of disease subtypes and genetic variants. Despite this growing wealth of information, the African population's access to genetic care and understanding of inherited risk and disease biology remain limited. This review summarizes the state of knowledge on genetic risk in African populations with breast cancer, evaluates the strengths and limitations of the methodological approaches used, and suggests innovative strategies to ensure equitable participation in cancer genetic and genomic research. We discuss genotype-phenotype correlations and the inherited risk of breast cancer, including both rare and common genetic variants. We also address the role of somatic drivers of breast cancer, disease biomarkers, treatment targets, and pharmacogenomics in this population. Finally, we provide recommendations to enable future progress in diagnosis and treatment.</p>","PeriodicalId":8231,"journal":{"name":"Annual review of genomics and human genetics","volume":" ","pages":""},"PeriodicalIF":7.7,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143966865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Matthew K Harner, Daniela V Bishop, Rebecca M Pollak, Ryan H Purcell, Jennifer G Mulle
{"title":"Copy Number Variants: Deletion and Duplication Syndromes.","authors":"Matthew K Harner, Daniela V Bishop, Rebecca M Pollak, Ryan H Purcell, Jennifer G Mulle","doi":"10.1146/annurev-genom-121222-120601","DOIUrl":"https://doi.org/10.1146/annurev-genom-121222-120601","url":null,"abstract":"<p><p>Rare genetic variants have illuminated mechanisms of common diseases and have even led to novel treatment approaches. Some copy number variants (CNVs) have been associated with extraordinary risk for complex neuropsychiatric phenotypes and thus offer a valuable entry point for investigating the biological mechanisms and pathways underlying autism, intellectual disability, and schizophrenia, among other neuropsychiatric disorders. For example, cellular and animal models of multiple CNVs have identified mitochondrial dysregulation as a key pathway underlying these disorders. In the clinic, there is a growing potential for improving the quality of life of individuals affected by these rare variants. Early targeted intervention leveraging data from robust clinical studies will be critical for providing patients and their families with the best possible outcomes. In this review, we highlight the current challenges and opportunities in the field of neurodevelopmental CNV research in both the lab and the clinic.</p>","PeriodicalId":8231,"journal":{"name":"Annual review of genomics and human genetics","volume":" ","pages":""},"PeriodicalIF":7.7,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143968030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Genomics of Aging at the Single-Cell Scale.","authors":"Wei Zhou, Junyue Cao","doi":"10.1146/annurev-genom-120523-024422","DOIUrl":"https://doi.org/10.1146/annurev-genom-120523-024422","url":null,"abstract":"<p><p>Aging is the primary risk factor for many diseases, including neurodegenerative disorders, cardiovascular diseases, and cancer. The rapid advancement of single-cell sequencing technologies has opened promising avenues for investigating aging-associated cellular changes that contribute to disrupted system homeostasis and increased vulnerability to age-related diseases. Despite the abundance of data generated over the past decade, a systematic understanding of how aging affects cell type-specific populations across the entire mammalian organism remains lacking-a critical gap for elucidating the cellular foundations of aging-related system dysfunction. In this review, we address this knowledge gap by summarizing recent single-cell studies examining the impact of aging on cell type-specific population changes across mammalian organs. We also review the impact of gender and anti-aging interventions on cell population dynamics in aged mammals. This work provides a comprehensive catalog of cellular states susceptible to aging, highlighting potential therapeutic targets for aging and age-related diseases.</p>","PeriodicalId":8231,"journal":{"name":"Annual review of genomics and human genetics","volume":" ","pages":""},"PeriodicalIF":7.7,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143967868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abby R Thurm, Geovanni L Janer Carattini, Lacramioara Bintu
{"title":"Human Synthetic Biology and Programmable Gene Regulation Control.","authors":"Abby R Thurm, Geovanni L Janer Carattini, Lacramioara Bintu","doi":"10.1146/annurev-genom-120423-013542","DOIUrl":"https://doi.org/10.1146/annurev-genom-120423-013542","url":null,"abstract":"<p><p>The growing field of human synthetic biology has rapidly accelerated the development of programmable genetic systems that can control cellular phenotypes and function. As the scale of synthetic systems has increased, researchers have focused on identifying modular regulators that act at the levels of DNA, RNA, and protein to create synthetic control points at each level of gene expression. Expanding these assays to multiple cellular contexts has made it possible to both manipulate endogenous gene programs and create synthetic gene circuits that yield designer cell outputs. Here, we review recent advances in high-throughput human synthetic biology that have led to the development of multilevel tools for gene expression control. We highlight the development of synthetic gene programs that can both provide information on and manipulate cellular behavior and discuss the application of programmable genetic tools in therapeutic contexts to illuminate the power of these new biological approaches.</p>","PeriodicalId":8231,"journal":{"name":"Annual review of genomics and human genetics","volume":" ","pages":""},"PeriodicalIF":7.7,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143975095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nicole B Halmai, Riley Taitingfong, Lydia L Jennings, Joseph Yracheta, Ibrahim Garba, Justin R Lund, Caleigh A Curley, Katrina G Claw, Maile Taualii, Nanibaa' A Garrison, Stephanie Russo Carroll
{"title":"Indigenous Data Sovereignty in Genomics and Human Genetics: Genomic Equity and Justice for Indigenous Peoples.","authors":"Nicole B Halmai, Riley Taitingfong, Lydia L Jennings, Joseph Yracheta, Ibrahim Garba, Justin R Lund, Caleigh A Curley, Katrina G Claw, Maile Taualii, Nanibaa' A Garrison, Stephanie Russo Carroll","doi":"10.1146/annurev-genom-022024-125543","DOIUrl":"https://doi.org/10.1146/annurev-genom-022024-125543","url":null,"abstract":"<p><p>As the field of genomics and human genetics continues to push our understanding of disease and biodiversity through an ever-increasing pool of genomic data, it is critical to consider the social, ethical, and legal implications of using such data. This is particularly true for genomic data pertaining to Indigenous Peoples, much of which has been collected and (re)used in research without the informed consent of Indigenous communities or without the return of benefits of research discoveries to these communities. Indigenous data sovereignty (IDSov) provides a framework through which Indigenous Peoples can assert their right to control data on or about their communities and lands. Here, we provide a review of IDSov and recommendations for how researchers can integrate it into their genomic research with Indigenous Peoples. Inclusion of IDSov in genomic research design supports meaningful partnerships between researchers and Indigenous communities, ensuring the maximization of benefits and minimization of harms for improved community health and prosperity.</p>","PeriodicalId":8231,"journal":{"name":"Annual review of genomics and human genetics","volume":" ","pages":""},"PeriodicalIF":7.7,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143953024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}